LCTX fundamentals
Lineage Cell Therapeutics, Inc. revenue breakdown overview
Lineage Cell Therapeutics, Inc. revenue for the last year amounted to 9.50 M USD, the most of which — 9.50 M USD — came from its highest performing source at the moment, Therapeutic Products, the year earlier bringing 8.95 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Lineage Cell Therapeutics, Inc. 9.50 M USD, and the year before that — 8.95 M USD.
By source
By country